API makers are looking for ways to slash costs and improve efficiencies to counter the impact currency fluctuations and other market challenges, earnings results from Lonza and BASF show.
Revenues from Pall’s biopharmaceuticals division grew in fiscal 2009, excluding foreign currency changes, with the company benefiting from the “thriving market” for vaccines and expanding adoption of single-use systems.
Copapharm Europe, the alliance of specialist packaging companies,
has announced "healthy" sales figures for 2005, as its
one-stop pan-European approach to the supply of pharmaceutical
packaging equipment is becoming more...
The Hovione Group revealed its yearly figures for 2005, which
revealed that sales grew by 8 per cent. The company's performance
is in contrast to the pharma fine chemicals sector, which between
2002 and 2004 had an average 14...
Yesterday, German chemicals group Degussa said that it had got off
to a good start financially in 2004. Today, the company provided a
more detailed breakdown of the first-quarter results which shows
the fine chemicals division still...
The Netherlands-based pharmaceuticals, coatings and chemicals firm
Akzo Nobel has posted a 7 per cent rise in net income to €176
million for the first quarter of 2004, a little more than expected,
but has warned that its pharmaceuticals...
Switzerland's Bachem saw its 2003 sales slip by 3 per cent as
continued slack demand for research chemicals held back a modest
increase in its active pharmaceutical ingredients business.